Suppr超能文献

吡非尼酮在体外伤口愈合中的抗血管生成作用。

The Antiangiogenesis Effect of Pirfenidone in Wound Healing In Vitro.

作者信息

Liu Xiao'an, Yang Yangfan, Guo Xiujuan, Liu Liling, Wu Kaili, Yu Minbin

机构信息

State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University , Guangzhou, People's Republic of China .

出版信息

J Ocul Pharmacol Ther. 2017 Nov;33(9):693-703. doi: 10.1089/jop.2017.0007. Epub 2017 Sep 21.

Abstract

UNLABELLED

Abstracts Purpose: Pirfenidone is mostly used in antifibrotic and anti-inflammatory therapies. We have previously demonstrated that pirfenidone had antifibrotic and anti-inflammatory effects on the wound healing process after glaucoma filtration surgery in vitro and in vivo. Since the wound healing and reactive scarring process simultaneously involves inflammation, fibrosis, and angiogenesis, and angiogenesis plays a more important role in chronic or prolonged wound healing, we tried to explore the antiangiogenesis effect in pirfenidone and its potential multitarget function in regulating excessive scarring. The aim of the present study was to investigate the antiangiogenesis effect of pirfenidone.

METHODS

The proliferation of human umbilical vein endothelial cells (HUVECs) and human Tenon's fibroblasts (HTFs) were detected by WST-1 assay. The cell viability of HUVECs was measured by Trypan Blue together with lactate dehydrogenase, Annexin 5 experiment, and Ki-67 immunofluorescence assay. The functions of HUVECs and HTFs were demonstrated using cell migration assay, transwell invasion assay, and tube formation assay. The expression levels of vascular endothelial growth factor-A (VEGF-A), VEGF receptor-2 (VEGFR-2), neuropilin-1(NRP-1), and their downstream signaling proteins p-PI3K, PI3K, p-AKT, AKT, p-mTOR, and mechanistic target of rapamycin (mTOR) were indicated by western blot assay. The secretion of VEGF-A was detected by enzyme-linked immunosorbent assay.

RESULTS

Pirfenidone inhibited proliferation, migration, invasion, and tube formation of HUVECs in vitro, and had an equivalent antiangiogenesis effect when compared with Ranibizumab in HUVECs and HTFs. Pirfenidone downregulated VEGF-A/VEGFR-2, VEGF-A/NRP-1, and its downstream signaling pathway protein expression.

CONCLUSIONS

Pirfenidone has an antiangiogenesis effect in the wound healing process and may become an ideal multitarget antiscarring agent after glaucoma filtration surgery.

摘要

未标记

摘要 目的:吡非尼酮主要用于抗纤维化和抗炎治疗。我们之前已经证明,吡非尼酮在体外和体内对青光眼滤过术后的伤口愈合过程具有抗纤维化和抗炎作用。由于伤口愈合和反应性瘢痕形成过程同时涉及炎症、纤维化和血管生成,并且血管生成在慢性或长期伤口愈合中起更重要的作用,我们试图探索吡非尼酮的抗血管生成作用及其在调节过度瘢痕形成中的潜在多靶点功能。本研究的目的是研究吡非尼酮的抗血管生成作用。

方法

采用WST-1法检测人脐静脉内皮细胞(HUVECs)和人Tenon成纤维细胞(HTFs)的增殖。用台盼蓝结合乳酸脱氢酶、Annexin 5实验和Ki-67免疫荧光测定法测定HUVECs的细胞活力。使用细胞迁移实验、transwell侵袭实验和管形成实验来证明HUVECs和HTFs的功能。通过蛋白质印迹法检测血管内皮生长因子-A(VEGF-A)、VEGF受体-2(VEGFR-2)、神经纤毛蛋白-1(NRP-1)及其下游信号蛋白p-PI3K、PI3K、p-AKT、AKT、p-mTOR和雷帕霉素靶蛋白(mTOR)的表达水平。通过酶联免疫吸附测定法检测VEGF-A的分泌。

结果

吡非尼酮在体外抑制HUVECs的增殖、迁移、侵袭和管形成,并且与雷珠单抗相比,在HUVECs和HTFs中具有同等的抗血管生成作用。吡非尼酮下调VEGF-A/VEGFR-2、VEGF-A/NRP-1及其下游信号通路蛋白的表达。

结论

吡非尼酮在伤口愈合过程中具有抗血管生成作用,并且可能成为青光眼滤过术后理想的多靶点抗瘢痕形成药物。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验